Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Annals of the Rheumatic Diseases|May 15, 2025
New IgG and IgA autoantibody specificities against DNA-binding and RNA-binding proteins discriminate systemic lupus erythematosus from health and non-lupus autoimmunity-could anti-LIN28A enhance precision in diagnostics?Ioannis Parodis, Denis Lagutkin, Julius Lindblom, et al.
Arthritis Research & Therapy|May 7, 2026
Peripheral blood transcriptomic analysis of patients with rheumatoid arthritis associated interstitial lung disease reveals: distinct molecular signature with evidence of humoral and myeloid immunitySofia Flouda, Maria Grigoriou, George Sentis, et al.
Annals of the Rheumatic Diseases|May 10, 2025
Novel IgG and IgA autoantibodies validated in two independent cohorts are associated with disease activity and determine organ manifestations in systemic lupus erythematosus: implications for anti-LIN28A, anti-HMGN5, anti-IRF5, and anti-TGIF1Julius Lindblom, Denis Lagutkin, Natalia Sherina, et al.
Kidney International Reports|June 20, 2024
Interferon and B-cell Signatures Inform Precision Medicine in Lupus NephritisIoannis Parodis, Julius Lindblom, Daniel Toro-Domínguez, et al.
Annals of the Rheumatic Diseases|April 12, 2024
Disentangling the riddle of systemic lupus erythematosus with antiphospholipid syndrome: blood transcriptome analysis reveals a less-pronounced IFN-signature and distinct molecular profiles in venous versus arterial eventsDionysis Nikolopoulos, Catherine Loukogiannaki, George Sentis, et al.
Cells|March 14, 2026
Glycomic Profiles of IgG, C3 and Alpha-1-Acid Glycoprotein (AGP) Before and One Year After Treatment for Active Lupus NephritisDionysis Nikolopoulos, Ana Cindrić, Konstantinos Charitidis, et al.
Annals of the Rheumatic Diseases|January 3, 2026
Untargeted breathomics identifies metabolic signatures of immune activity, intestinal integrity, and fatigue in systemic lupus erythematosusIoannis Parodis, Martina Iacubino, Lorenzo Rocco, et al.
Journal of Translational Autoimmunity|July 17, 2025
Dysregulation of innate and adaptive lymphoid immunity may have implications for symptom attribution and predict responses to targeted therapies in neuropsychiatric systemic lupus erythematosusJulius Lindblom, Guillermo Barturen, Lorenzo Beretta, et al.
RMD Open|March 13, 2025
Transcriptome analysis to decipher the molecular underpinnings of response to treatment in systemic lupus erythematosusPanagiotis Garantziotis, Georgia Savina Moysidou, Noemin Kapsala, et al.
Frontiers in Immunology|January 23, 2023
Clinical response trajectories and drug persistence in systemic lupus erythematosus patients on belimumab treatment: A real-life, multicentre observational studyMyrto Nikoloudaki, Dionysis Nikolopoulos, Sofia Koutsoviti, et al.
Pageof 6